Fida Biosystems
PrivateLast Round
Series A
Extension
Dec 16, 2025
Total Funding Raised
$9.36M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Fida Biosystems operates in Healthcare & Life Sciences and is based in Denmark. Its latest recorded funding round was a Series A Extension round in December 2025.
Fida Biosystems is a biotechnology company that develops advanced analytical platforms based on its proprietary Flow Induced Dispersion Analysis (FIDA) technology for biophysical analysis of biomolecules and nanoparticles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fida Biosystems Comparables
Compare Fida Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoTemper Technologies | 86% | |
| FOx Biosystems | 86% | |
| Depixus | 83% |
For institutional investors. Book with your work email.
Fida Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 16, 2025 | ||||
| Grant | May 29, 2020 | ||||
| Series A | Dec 18, 2019 | ||||
| Grant | Dec 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fida Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Fåhraeus Startup and Growth | Series A Extension |
| The Export and Investment Fund of Denmark | Series A Extension, Series A |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
$5.4M round led by Fåhraeus Startup and Growth.
- May 15, 2025
Added Eisai GmbH, a pharmaceutical company, as a customer.
For institutional investors. Book with your work email.
Fida Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fida Biosystems's valuation, stock price, and market status.
Is Fida Biosystems a public or private company?
Fida Biosystems is a private company.
What is the current stock price of Fida Biosystems?
Fida Biosystems is a private company, so its shares have no public market price. Caplight tracks Fida Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fida Biosystems worth (valuation)?
Valuation information for Fida Biosystems is not publicly available.
Can I buy Fida Biosystems stock?
Fida Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fida Biosystems's last funding round?
Fida Biosystems's most recent funding round was Series A Extension on December 16, 2025.
Who are the main investors in Fida Biosystems?
Key investors in Fida Biosystems include Innovation Fund Denmark, Fåhraeus Startup and Growth, The Export and Investment Fund of Denmark, European Union.
Will Fida Biosystems IPO soon?
No public IPO plans have been announced for Fida Biosystems.
How can I track Fida Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Fida Biosystems's shares on secondary markets.